Prior authorizations were reported by 74% of cancer survivors, of whom half of personally resolved it, representing a large time burden.
The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...
More than 4100 federal workers were terminated, with 700 reinstated shortly after, sparking concerns about US public health preparedness and transparency.
The second RZV dose increased immunity against herpes zoster virus outcomes when administered within an extended window after the first dose.
Melanoma survivors with a SPCM or a SPNCM had worse overall survival rates when compared with those who only had 1 primary melanoma.
Nearly 700 medicines used in the US to treat common conditions contain at least 1 chemical sourced only in China.
The use of ROM terminology on pathology requisition forms has a relatively low positive predictive value for a diagnosis of melanoma.
Reports of lidocaine poisoning increased but reports of local anesthetic poisonings decreased following the 2010 advisories.
The prevalence of maternal cardiovascular comorbidities, disease, and complications increased from 2001 to 2019.
The incidence of dermatologic disease among people with HIV decreased from 2011 to 2023, but it remains prevalent.
The current law, which bans abortion after 6 weeks of pregnancy, would instead start as soon as pregnancy can be medically detected.
Results of a phase 2 trial suggest that ruxolitinib cream 1.5% may be an effective treatment option for adults with nonatopic chronic hand eczema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results